Fact Sheet 12 mar 2024 The fintech sector in the United Arab Emirates The United Arab Emirates (UAE) has a strong digital infrastructure, government-supported incubators, a young and tech-savvy population, and a lar...
Aktuell 21 nov 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
Factsheet 12 mar 2024 Die Fintech-Branche in den Vereinigten Arabischen Emiraten Die Vereinigten Arabischen Emirate (VAE) verfügen über eine starke digitale Infrastruktur, staatlich geförderte Gründerzentren, eine junge und te...
Fiches d’information 11 mar 2024 Le secteur des fintech des Emirats arabes unis Les Émirats arabes unis (EAU) ont de solides atouts: une bonne infrastructure numérique, des incubateurs soutenus par le gouvernement, une popula...
Factsheet 11 mar 2024 Il settore fintech negli Emirati Arabi Uniti Gli Emirati Arabi Uniti (EAU) vantano molti punti di forza: una buona infrastruttura digitale, incubatori sostenuti dal governo, una popolazione ...
News 21 nov 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
News 12 jun 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
News 11 jan 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 17 mai 2023 Geneva start-ups Fluosphera, Kylys Aesthetics and Consulto receive FIF support The Fondation Genevoise pour l’Innovation Technologique (Fongit) has announced the latest recipients of the Fongit Innovation Fund (FIF) support....
News 22 mar 2023 FIF funding awarded to three innovative Geneva-based projects Geneva-based start-ups Plair, Endotelix, and Dr. Beat Walpoth have received the Fongit Innovation Fund (FIF) for their remarkable innovations.